Analytical Testing
AccuStem Sciences Signs Agreement to Access Blood Samples From Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
AccuStem Sciences, Inc.recently announced a development agreement to access blood samples from the multi-institutional, prospective, randomized Rete Italiana di Screening Polmonare (RISP) clinical trial. This…
SPECIAL FEATURE - Analytical Testing – Diverse Demands & Therapies Require Diverse Analyses
Contributor Cindy H. Dubin highlights how analytical testing has evolved to address diverse pharmaceutical therapeutics in research and development.
2025 COMPANY PROFILES & CAPABILITIES
For each participating company, this section presents a detailed summary highlighting their core technologies, capabilities, technologies, and services.
EXECUTIVE INTERVIEW - Lonza: Utilizing Analytical Tools & Predictive Models to De-Risk Drug Development
Drug Development & Delivery recently interviewed Josh Marsh, Bioavailability Enhancement and PBPK Lead Scientist at Lonza, to discuss the benefits of predictive tools and Lonza’s approach.
SGS Announces Expansion of Biopharmaceutical Testing Capabilities
SGS recently announced it has added new capacity and capabilities at its center of excellence in Lincolnshire, IL. This expansion adds new instrumentation and expertise…
LGM Pharma Expands Analytical Testing Services With New Endotoxin & Rapid Sterility Testing Capabilities
LGM Pharma recently announced today expansion of its Analytical Testing Services (ATS) with the addition of endotoxin and rapid sterility testing capabilities. These new services,…
SGS Announces Expansion of Biopharmaceutical Testing Capabilities
SGS recently announced it has added new capacity and capabilities at its center of excellence in Lincolnshire, IL. This expansion adds new instrumentation and expertise…
SGS’s Shanghai Health Science Laboratory Completes FDA Inspection With Zero 483 Observations
SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection…
Pace Life Sciences Expands Capacity & Capability With Acquisition of Catalent’s Analytical Services Laboratory
Pace Life Sciences, LLC recently announced it has acquired from Catalent its Center-of-Excellence for Small Molecule Analytical Services located in Research Triangle Park (RTP), NC.…
Serán Bioscience Announces $200-Million Strategic Growth Transaction & Plans for New Commercial Facility
Serán Bioscience recently announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital…
Sapio Sciences Advances The World's First AI-Powered Lab Assistant
Sapio Sciences recently announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Sapio ELaiN, now…
SGS Introduces New Specialized Bioanalytical Testing Services in North America
SGS, the world’s leading testing, inspection and certification company, announces the introduction of new specialized bioanalytical testing services in the North American pharmaceutical and biopharmaceutical…
2024 Analytical Testing eBook - Providers Offer Versatile, Advanced & Expanded Services
Learn more about Stevanato Group and LGM Pharma in this exclusive Drug Development & Delivery annual Analytical Testing eBook.
Sapio Sciences & Zifo Announce Strategic Partnership
Sapio Sciences and Zifo recently announced a strategic partnership to bring best-in-class laboratory information management solutions to customers across the biotech, clinical diagnostics, and pharmaceutical…
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery & Development of Therapies
Thermo Fisher Scientific Inc. recently introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the only fully automated maxi-scale plasmid DNA (pDNA) purification system. PlasmidPro…
DRUG DISCOVERY - Addressing Challenges in Drug Discovery: DEL Screening Applications
Matt Clark, PhD, explores DEL’s application in three areas of drug discovery that have received much attention throughout the past 5 years: Induced Proximity, Covalent Drug Discovery, and Machine Learning.
Bio-Rad Launches Validated Antibodies for Rare Cell & Circulating Tumor Cell Enumeration
Bio-Rad Laboratories, Inc. recently announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect…
Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus & Replication Competent AAV Kits for Cell & Gene Therapy Production
Bio-Rad Laboratories, Inc. recently announced the launch of the Vericheck ddPCR Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The kits provide rapid….
Study Demonstrates the Potential of HelixBind’s RaPID/BSI Assay to Accurately Identify Bloodstream Infections Associated With Sepsis in Patients Undergoing Antimicrobial Treatment
HelixBind, Inc. recently announced the publication of a peer-reviewed study demonstrating the capability of the company’s RaPID/BSI assay to accurately identify bloodstream infections associated with…
Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies
Abzena recently announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large molecules, which significantly….
